print

News

All Releases
Curis Announces Collaborators' Presentation of Erivedge(TM) and Debio 0932 Clinical Data at ASCO Annual Meeting
May 17, 2012
PDF 13.9 KB Add to Briefcase
Curis Reports First Quarter 2012 Financial Results
May 8, 2012
PDF 19.6 KB Add to Briefcase
Curis Announces Collaborator Roche's Submission of Erivedge(TM) for Registration With Australian Regulatory Authority
May 7, 2012
PDF 11.3 KB Add to Briefcase
Curis to Release First Quarter 2012 Financial Results and Hold Conference Call on May 8, 2012
May 1, 2012
PDF 8.6 KB Add to Briefcase
Curis to Present at the Deutsche Bank Securities 37th Annual Health Care Conference
Apr 30, 2012
PDF 8.8 KB Add to Briefcase
Curis to Present at the BioCentury Future Leaders in the Biotech Industry Conference
Apr 13, 2012
PDF 8.8 KB Add to Briefcase
Curis Presents Data on PI3K and HDAC Inhibitor CUDC-907 at AACR Annual Meeting 2012
Apr 4, 2012
PDF 13.1 KB Add to Briefcase
Curis to Present at the 11th Annual Needham Healthcare Conference
Mar 28, 2012
PDF 8.9 KB Add to Briefcase
Curis to Present at the Roth 24th Annual OC Growth Stock Conference
Mar 6, 2012
PDF 8.6 KB Add to Briefcase
Curis to Present at the 32nd Annual Cowen and Company Health Care Conference
Feb 27, 2012
PDF 8.9 KB Add to Briefcase
Curis to Present at the 2012 RBC Capital Markets' Healthcare Conference
Feb 21, 2012
PDF 8.6 KB Add to Briefcase
Curis to Present at the Citi 2012 Global Healthcare Conference
Feb 17, 2012
PDF 9.0 KB Add to Briefcase
Curis and Debiopharm Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932
Feb 16, 2012
PDF 51.2 KB Add to Briefcase
Curis Reports Fourth Quarter and Year-End 2011 Financial Results
Feb 8, 2012
PDF 25.3 KB Add to Briefcase
Curis to Present at the 14th Annual BIO CEO & Investor Conference
Feb 6, 2012
PDF 9.0 KB Add to Briefcase
Curis to Release Fourth Quarter and Year-End 2011 Financial Results and Hold Conference Call on February 8, 2012
Feb 1, 2012
PDF 8.7 KB Add to Briefcase
Curis Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma
Jan 30, 2012
PDF 17.4 KB Add to Briefcase
Curis Announces Collaborator Roche's Submission of Marketing Authorization Application for Vismodegib in Advanced Basal Cell Carcinoma
Dec 22, 2011
PDF 13.9 KB Add to Briefcase
Curis to Present at the Oppenheimer & Company's 22nd Annual Healthcare Conference
Dec 6, 2011
PDF 9.3 KB Add to Briefcase
Curis Announces Agreement with The Leukemia & Lymphoma Society to Develop CUDC-907 for Lymphoma and Multiple Myeloma
Nov 30, 2011
PDF 13.3 KB Add to Briefcase
Showing 1-20 of 187 Page: 1 2 3 4 5 ... 10  Next 20
Add to Briefcase = add file to Briefcase

© Curis Inc. 2012 - All Rights Reserved